Sonova Holding AG

SWX:SOON Stock Report

Market Cap: CHF 16.5b

Sonova Holding Valuation

Is SOON undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of SOON when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: SOON (CHF277.6) is trading below our estimate of fair value (CHF463.13)

Significantly Below Fair Value: SOON is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SOON?

Other financial metrics that can be useful for relative valuation.

SOON key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue4.9x
Enterprise Value/EBITDA21.3x
PEG Ratio2.8x

Price to Earnings Ratio vs Peers

How does SOON's PE Ratio compare to its peers?

The above table shows the PE ratio for SOON vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average48x
STMN Straumann Holding
72.1x20.9%CHF 17.7b
MOVE Medacta Group
53.1x20.0%CHF 2.4b
METN Metall Zug
25x7.3%CHF 555.8m
ALC Alcon
42x9.5%CHF 39.7b
SOON Sonova Holding
27.5x9.9%CHF 16.5b

Price-To-Earnings vs Peers: SOON is good value based on its Price-To-Earnings Ratio (27.5x) compared to the peer average (48x).

Price to Earnings Ratio vs Industry

How does SOON's PE Ratio compare vs other companies in the European Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a14.7%
 n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a14.7%
 n/an/an/a
No more companies

Price-To-Earnings vs Industry: SOON is good value based on its Price-To-Earnings Ratio (27.5x) compared to the European Medical Equipment industry average (30.3x).

Price to Earnings Ratio vs Fair Ratio

What is SOON's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SOON PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio27.5x
Fair PE Ratio37x

Price-To-Earnings vs Fair Ratio: SOON is good value based on its Price-To-Earnings Ratio (27.5x) compared to the estimated Fair Price-To-Earnings Ratio (37x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst SOON forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCHF 280.30
CHF 284.82
+1.6%
11.8%CHF 335.00CHF 220.00n/a17
Jun ’25CHF 284.80
CHF 279.12
-2.0%
12.6%CHF 335.00CHF 220.00n/a17
May ’25CHF 255.40
CHF 270.29
+5.8%
11.4%CHF 325.00CHF 200.00n/a17
Apr ’25CHF 261.10
CHF 270.65
+3.7%
12.0%CHF 325.00CHF 200.00n/a17
Mar ’25CHF 276.50
CHF 270.59
-2.1%
13.4%CHF 325.00CHF 200.00n/a17
Feb ’25CHF 279.10
CHF 267.06
-4.3%
14.7%CHF 325.00CHF 200.00n/a16
Jan ’25CHF 274.40
CHF 257.07
-6.3%
12.7%CHF 320.00CHF 200.00n/a15
Dec ’24CHF 255.80
CHF 259.75
+1.5%
13.4%CHF 340.00CHF 200.00n/a16
Nov ’24CHF 217.30
CHF 249.50
+14.8%
15.8%CHF 340.00CHF 195.00n/a16
Oct ’24CHF 217.70
CHF 252.81
+16.1%
16.3%CHF 340.00CHF 195.00n/a16
Sep ’24CHF 233.10
CHF 253.59
+8.8%
15.4%CHF 331.00CHF 195.00n/a17
Aug ’24CHF 242.50
CHF 253.59
+4.6%
15.4%CHF 331.00CHF 195.00n/a17
Jul ’24CHF 238.20
CHF 254.76
+7.0%
14.8%CHF 331.00CHF 195.00CHF 280.3017
Jun ’24CHF 235.70
CHF 248.91
+5.6%
14.6%CHF 320.00CHF 180.30CHF 284.8018
May ’24CHF 281.80
CHF 257.58
-8.6%
15.1%CHF 330.00CHF 180.30CHF 255.4016
Apr ’24CHF 268.60
CHF 257.33
-4.2%
15.2%CHF 330.00CHF 180.30CHF 261.1016
Mar ’24CHF 231.40
CHF 258.71
+11.8%
15.4%CHF 330.00CHF 180.30CHF 276.5016
Feb ’24CHF 233.40
CHF 258.71
+10.8%
15.4%CHF 330.00CHF 180.30CHF 279.1016
Jan ’24CHF 219.30
CHF 286.21
+30.5%
20.7%CHF 450.00CHF 180.30CHF 274.4016
Dec ’23CHF 248.10
CHF 291.29
+17.4%
20.0%CHF 450.00CHF 180.30CHF 255.8015
Nov ’23CHF 234.80
CHF 305.21
+30.0%
16.9%CHF 450.00CHF 255.00CHF 217.3014
Oct ’23CHF 220.00
CHF 335.00
+52.3%
13.6%CHF 450.00CHF 257.00CHF 217.7013
Sep ’23CHF 252.60
CHF 338.08
+33.8%
13.8%CHF 450.00CHF 257.00CHF 233.1013
Aug ’23CHF 341.00
CHF 372.00
+9.1%
11.8%CHF 450.00CHF 290.00CHF 242.5012
Jul ’23CHF 309.60
CHF 373.92
+20.8%
15.6%CHF 470.00CHF 257.00CHF 238.2013

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.